Pharmacokinetics and pharmacodynamics of huangqin tang in febrile rats

Tao LI; Yi-Wei WANG; Yan-Li WANG; Dong ZHANG; Hui-Hui ZHANG; Li CHEN; Shuai-Xing ZHUANG; Zhong-Ming ZHOU; Wei-Peng YANG.
Acta Pharmaceutica Sinica ; (12): 1418-1425, 2014.
Artículo en Zh | WPRIM | ID: wpr-299118

Documentos relacionados

  1. Training the next generation of pharmacometric modelers: a multisector perspective.
  2. Low-dimensional neural ODEs and their application in pharmacokinetics.
  3. Determination of the Number of Tissue Groups of Kinetically Distinct Transit Time in Whole-Body Physiologically Based Pharmacokinetic (PBPK) Models I: Theoretical Consideration of Bottom-Up Approach of Lumping Tissues in Whole-Body PBPK.
  4. Properties of the Urothelium that Establish the Blood-Urine Barrier and Their Implications for Drug Delivery.
  5. Machine Learning Models for Human <i>In Vivo</i> Pharmacokinetic Parameters with In-House Validation.
  6. [Pharmacokinetics and pharmacodynamics of huangqin tang in febrile rats].
  7. The Finite Absorption Time (FAT) concept en route to PBPK modeling and pharmacometrics.
  8. Application of physiologically based pharmacokinetic models for therapeutic proteins and other novel modalities.
  9. Assessment of the nlmixr R package for population pharmacokinetic modeling: A metformin case study.
  10. Development of a genetic algorithm and NONMEM workbench for automating and improving population pharmacokinetic/pharmacodynamic model selection.